Your browser doesn't support javascript.
loading
Computationally Designed Bispecific Antibodies using Negative State Repertoires.
Leaver-Fay, Andrew; Froning, Karen J; Atwell, Shane; Aldaz, Hector; Pustilnik, Anna; Lu, Frances; Huang, Flora; Yuan, Richard; Hassanali, Saleema; Chamberlain, Aaron K; Fitchett, Jonathan R; Demarest, Stephen J; Kuhlman, Brian.
Afiliação
  • Leaver-Fay A; Department of Biochemistry, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Campus Box 7260, Chapel Hill, NC 27599, USA.
  • Froning KJ; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Atwell S; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Aldaz H; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Pustilnik A; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Lu F; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Huang F; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Yuan R; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Hassanali S; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Chamberlain AK; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Fitchett JR; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA.
  • Demarest SJ; Eli Lilly Biotechnology Center, 10300 Campus Point Drive, Suite 200, San Diego, CA 92121, USA. Electronic address: demarestsj@lilly.com.
  • Kuhlman B; Department of Biochemistry, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Campus Box 7260, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 101 Manning Drive, Chapel Hill, NC 27514, USA. Electronic address: bkuhlman@
Structure ; 24(4): 641-651, 2016 Apr 05.
Article em En | MEDLINE | ID: mdl-26996964
ABSTRACT
A challenge in the structure-based design of specificity is modeling the negative states, i.e., the complexes that you do not want to form. This is a difficult problem because mutations predicted to destabilize the negative state might be accommodated by small conformational rearrangements. To overcome this challenge, we employ an iterative strategy that cycles between sequence design and protein docking in order to build up an ensemble of alternative negative state conformations for use in specificity prediction. We have applied our technique to the design of heterodimeric CH3 interfaces in the Fc region of antibodies. Combining computationally and rationally designed mutations produced unique designs with heterodimer purities greater than 90%. Asymmetric Fc crystallization was able to resolve the interface mutations; the heterodimer structures confirmed that the interfaces formed as designed. With these CH3 mutations, and those made at the heavy-/light-chain interface, we demonstrate one-step synthesis of four fully IgG-bispecific antibodies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Fragmentos Fc das Imunoglobulinas / Engenharia de Proteínas / Cadeias Pesadas de Imunoglobulinas / Anticorpos Biespecíficos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Fragmentos Fc das Imunoglobulinas / Engenharia de Proteínas / Cadeias Pesadas de Imunoglobulinas / Anticorpos Biespecíficos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article